Opatanol (Olopatadine)

Olopatadine, the active ingredient in Opatanol, is an antihistamine presented as an ophthalmic solution for topical ocular use. It alleviates symptoms of allergic conjunctivitis, such as itching, redness, and tearing, in both adult and pediatric patients, and improves visual comfort.

GNH USA supplies Opatanol as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to stringent quality standards and regulatory requirements. The company provides the product to hospitals, pharmacies and clinics worldwide, supporting global access to reliable ophthalmic therapies and dependable distribution networks.

Olopatadine is an antihistamine used to manage allergic ocular conditions.

Allergic conjunctivitis: reduces ocular itching, redness, and tearing. Seasonal allergic conjunctivitis: provides symptom relief during pollen seasons. Perennial allergic conjunctivitis: controls chronic eye allergy symptoms year‑round.

Common Side Effects: - Transient eye irritation or burning sensation. - Bitter taste after administration. - Mild headache. - Blurred vision that resolves quickly. - Dry eye feeling. - Mild conjunctival hyperemia.

Serious or Rare Side Effects: - Severe eye pain or corneal ulceration. - Significant vision changes. - Allergic reactions such as angioedema or anaphylaxis. - Persistent redness or swelling. - Intraocular pressure increase. - Systemic hypersensitivity reactions.

Precautions should be observed when using Opatanol. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Use in children: safety established for approved pediatric age groups only. - Contact lens wear: remove lenses for at least 15 minutes after instillation. - Hypersensitivity: do not use if allergic to olopatadine or any excipients. - Store at room temperature: keep in the original container, protect from moisture and light.

Potential drug interactions may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use of ocular anesthetics may increase risk of corneal toxicity.

Moderate Interactions (Monitor Closely): - Systemic antihistamines may reduce the local efficacy of Opatanol. - Topical corticosteroids used together may elevate intra‑ocular pressure. - Preservative‑containing contact lens solutions can cause additional irritation. - Other mast‑cell stabilizers may produce additive ocular effects.